brl 35135 has been researched along with sq-11725 in 2 studies
Studies (brl 35135) | Trials (brl 35135) | Recent Studies (post-2010) (brl 35135) | Studies (sq-11725) | Trials (sq-11725) | Recent Studies (post-2010) (sq-11725) |
---|---|---|---|---|---|
38 | 3 | 1 | 878 | 223 | 125 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lipworth, BJ; McDevitt, DG; McFarlane, LC; Wheeldon, NM | 1 |
Lipworth, BJ; McDevitt, DG; Wheeldon, NM | 1 |
2 trial(s) available for brl 35135 and sq-11725
Article | Year |
---|---|
Beta-adrenoceptor subtypes mediating the metabolic effects of BRL 35135 in man.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Basal Metabolism; Bisoprolol; Blood Glucose; Fatty Acids, Nonesterified; Glycerol; Humans; Insulin; Lactates; Lactic Acid; Male; Nadolol; Phenethylamines; Potassium; Single-Blind Method | 1994 |
Cardiac effects of the beta 3-adrenoceptor agonist BRL35135 in man.
Topics: Administration, Oral; Adrenergic beta-Agonists; Adult; Albuterol; Bisoprolol; Drug Interactions; Hemodynamics; Humans; Male; Myocardial Contraction; Nadolol; Phenethylamines; Tremor | 1994 |